相关实验视频

Updated: Jun 29, 2025

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

用于自身免疫疗法的CD25偏差型互白素-2,通过半合成生物体进行工程设计

Jerod L Ptacin¹, Lina Ma¹, Carolina E Caffaro¹

¹Synthorx, a Sanofi Company, 11099 N. Torrey Pines Rd. Suite 190, La Jolla, CA, 92037, USA.

Communications medicine

|March 27, 2024

概括

这项研究设计了一种名为SAR444336的基复合人间白蛋白-2 (rhIL-2),专门激活免疫抑制调节T细胞 (Tregs),用于治疗自身免疫性疾病.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

天然细胞因子对系统管理具有较差的治疗性质.
复合人间白素-2 (rhIL-2) 显示出自身免疫性疾病的潜力,但具有短半衰期和对抗免疫反应等局限性.

研究的目的:

为了设计一种改进的rhil-2具有改善的药理动力学特性和向的免疫抑制活性.
通过增强调控性T细胞 (Treg) 诱导,开发一种治疗自身免疫性疾病的候选药物.

主要方法:

利用半合成微生物平台创建特定站点的基化rhIL-2变体.
采用生物对角化学来安装非正规氨基酸以实现精确的基化.
对IL-2受体组件的选择性参与进行选的变体,以有利于Treg扩张.

主要成果:

确定了SAR444336 (pegylated rhIL-2在H16) 作为一种选择性扩展外围CD4+Tregs的候选物.
在小鼠和非人类灵长类动物中观察到Treg抑制标记物 (FoxP3,ICOS,Helios) 的上调,效应T和NK细胞的扩张最小.
在推迟类型过敏症的小鼠模型中,证明减少了炎症和T细胞增殖.

结论:

SAR444336作为一个特定的Treg激活剂.
这些发现支持进一步开发SAR444336用于治疗自身免疫性疾病.

更多相关视频

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.